We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
–
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
+$51.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$239M
2
RNAM
Avidity Biosciences
RNAM
+$210M
3
AAPL icon
Apple
AAPL
+$183M
4
AMD icon
Advanced Micro Devices
AMD
+$98.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$91.7M

Sector Composition

Rank Sector Weight
1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASTLW icon
201
Algoma Steel Group Warrant
ASTLW
$387K
$311K 0.01%
180,517
+7,100
+4% +$10.2K
SMMT icon
202
CALL
Summit Therapeutics
SMMT
$10.9B
$311K 0.01%
25,000
– –
SGML icon
203
Sigma Lithium
SGML
$1.08B
$309K 0.01%
25,000
-109,300
-81% -$1.19M
CRWD icon
204
PUT
CrowdStrike
CRWD
$187B
$297K 0.01%
40,000
– –
RTX icon
205
CALL
RTX Corp
RTX
$287B
$297K 0.01%
43,200
-6,800
-14% -$776K
ETWO.WS
206
DELISTED
E2open Parent Holdings, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
ETWO.WS
$297K 0.01%
1,744,646
-8,913
-0.5% -$1.47K
CHPT icon
207
CALL
ChargePoint
CHPT
$133M
$295K 0.01%
280,205
+94,155
+51% +$3.27M
EWTX icon
208
Edgewise Therapeutics
EWTX
$4.39B
$294K 0.01%
+11,000
New +$219K
CORZZ icon
209
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.86B
$293K 0.01%
24,919
-402,100
-94% -$4.14M
EVH icon
210
Evolent Health
EVH
$475M
$283K 0.01%
+10,000
New +$258K
MDXH icon
211
MDxHealth
MDXH
$21.1M
$281K 0.01%
+135,090
New +$367K
BKHAR
212
Black Hawk Acquisition Corp Rights
BKHAR
$279K 0.01%
240,886
-7,481
-3% -$9.38K
PHAT icon
213
Phathom Pharmaceuticals
PHAT
$912M
$271K 0.01%
+15,000
New +$210K
USARW
214
DELISTED
USA Rare Earth Inc Warrant
USARW
$270K 0.01%
1,131,500
+358,800
+46% +$61.1K
BSMU icon
215
Invesco BulletShares 2030 Municipal Bond ETF
BSMU
$264M
$269K 0.01%
+12,142
New +$267K
HLN icon
216
Haleon
HLN
$43.1B
$265K 0.01%
+25,000
New +$242K
CITEW
217
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$261K 0.01%
1,630,736
+804,379
+97% +$128K
PPYA
218
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$260K 0.01%
23,508
-1,456
-6% -$16.3K
QQQ icon
219
PUT
Invesco QQQ Trust
QQQ
$455B
$260K 0.01%
61,400
+34,300
+127% +$16.2M
RHI icon
220
Robert Half
RHI
$3.61B
$256K 0.01%
+3,800
New +$241K
APLT
221
DELISTED
Applied Therapeutics
APLT
$255K 0.01%
+30,000
New +$177K
BNY
222
CALL
Bank of New York Mellon
BNY
$108B
$252K 0.01%
33,000
-61,300
-65% -$4.03M
AIRJW
223
AirJoule Technologies Warrant
AIRJW
$62M
$252K 0.01%
+599,996
New +$521K
SBXD.U
224
SilverBox Corp IV Units
SBXD.U
$252K 0.01%
+25,115
New +$251K
SOC.WS
225
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$251K 0.01%
20,748
-240,253
-92% -$1.69M
7 8
9
10 11

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.